This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignee: University of Southern California. Active years: 2017-2023.
Company Filing History:
Years Active: 2017-2023
Title: Kevin J Gaffney: Innovator in Stem Cell Research
Introduction
Kevin J Gaffney is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of stem cell research, holding a total of 7 patents. His work focuses on innovative methods that have the potential to impact medical treatments.
Latest Patents
Among his latest patents are groundbreaking methods for increasing circulating mesenchymal stem cells. These methods involve administering a compound with a specific general formula or a pharmaceutically acceptable salt thereof. Additionally, he has developed methods for treating systemic lupus erythematosus (SLE). This treatment is based on administering a polypeptide that includes angiotensin 1-7 (A(1-7)), Nle3A 1-7, or a compound according to a defined general formula.
Career Highlights
Kevin has worked with notable institutions, including the University of Southern California. His research and innovations have contributed to advancements in medical science, particularly in the area of autoimmune diseases and regenerative medicine.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues such as Kathleen Elizabeth Rodgers and Stan G Louie. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Kevin J Gaffney's innovative work in stem cell research and treatment methods showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.